Targeting PP2A to overcome enzalutamide resistance in AR plus breast tumors

被引：1
|
作者：
Cristobal, Ion [1 ]
Torrejon, Blanca [1 ]
Pedregal, Manuel [1 ]
Rojo, Federico [2 ]
Garcia-Foncillas, Jesus [1 ]
机构：
[1] Univ Hosp Fdn Jimenez Diaz, IIS Fdn Jimenez Diaz UAM, Translat Oncol Div, Oncohlth Inst, Madrid, Spain
[2] Univ Hosp Fdn Jimenez Diaz, IIS Fdn Jimenez Diaz UAM, Pathol Dept, Madrid, Spain
来源：
ENDOCRINE-RELATED CANCER | 2017年 / 24卷 / 01期
关键词：
ANDROGEN RECEPTOR; PROSTATE-CANCER; INHIBITOR; EXPRESSION; CELLS; AXIS;
D O I：
10.1530/ERC-16-0444
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：L5 / L6
页数：2
相关论文
共 50 条
  • [21] Targeting of JAK-STAT Signaling in Breast Cancer: Therapeutic Strategies to Overcome Drug Resistance
    Tabassum, Sobia
    Abbasi, Rashda
    Ahmad, Nafees
    Farooqi, Ammad Ahmad
    BREAST CANCER METASTASIS AND DRUG RESISTANCE: CHALLENGES AND PROGRESS, 2ND EDITION, 2019, 1152 : 271 - 281
  • [22] Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+breast cancer
    Liu, Yunhua
    Xu, Jiangsheng
    Choi, Hyun Ho
    Han, Cecil
    Fang, Yuanzhang
    Li, Yujing
    Van der Jeught, Kevin
    Xu, Hanchen
    Zhang, Lu
    Frieden, Michael
    Wang, Lifei
    Eyvani, Haniyeh
    Sun, Yifan
    Zhao, Gang
    Zhang, Yuntian
    Liu, Sheng
    Wan, Jun
    Huang, Cheng
    Ji, Guang
    Lu, Xiongbin
    He, Xiaoming
    Zhang, Xinna
    NATURE COMMUNICATIONS, 2018, 9
  • [23] Specific Targeting of Caspase-9/PP2A Interaction as Potential New Anti-Cancer Therapy
    Arrouss, Issam
    Nemati, Fariba
    Roncal, Fernando
    Wislez, Marie
    Dorgham, Karim
    Vallerand, David
    Rabbe, Nathalie
    Karboul, Narjesse
    Carlotti, Francoise
    Bravo, Jeronimo
    Mazier, Dominique
    Decaudin, Didier
    Rebollo, Angelita
    PLOS ONE, 2013, 8 (04):
  • [24] Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells
    Zhao, Qingxia
    Zhao, Ming
    Parris, Amanda B.
    Xing, Ying
    Yang, Xiaohe
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (03) : 1203 - 1210
  • [25] Polymer Nanoparticles Overcome Drug Resistance by a Dual-Targeting Apoptotic Signaling Pathway in Breast Cancer
    Li, Ning
    Gao, Dong
    Li, Chen
    Wang, Baiqi
    Li, Boying
    Bao, Benkai
    Wu, Manman
    Li, Mengying
    Xing, Chengfen
    ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (20) : 23117 - 23128
  • [26] Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
    Sobhani, Navid
    Fassl, Anne
    Mondani, Giuseppina
    Generali, Daniele
    Otto, Tobias
    CELLS, 2021, 10 (02) : 1 - 14
  • [27] Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors
    Lettau, Konstanze
    Khozooei, Shayan
    Kosnopfel, Corinna
    Zips, Daniel
    Schittek, Birgit
    Toulany, Mahmoud
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 1072 - 1087
  • [28] Dual targeting of HER3 and EGFR in colorectal tumors might overcome anti-EGFR resistance
    Temraz, Sally
    Mukherji, Deborah
    Shamseddine, Ali
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 : 151 - 157
  • [29] Overexpression of BQ323636.1 contributes to anastrozole resistance in AR plus ve/ER plus ve breast cancer
    Tsoi, Ho
    Lok, Johann
    Man, Ellen P. S.
    Cheng, Cheuk-Nam
    Leung, Man-Hong
    You, Chan-Ping
    Chan, Sum-Yin
    Chan, Wing-Lok
    Khoo, Ui-Soon
    JOURNAL OF PATHOLOGY, 2023, 261 (02): : 156 - 168
  • [30] Targeting an MDM2/MYC Axis to Overcome Drug Resistance in Multiple Myeloma
    Faruq, Omar
    Zhao, Davidson
    Shrestha, Mariusz
    Vecchione, Andrea
    Zacksenhaus, Eldad
    Chang, Hong
    CANCERS, 2022, 14 (06)
12345